How SARS-CoV-2 evolved from a bat-to a human-adapted virus

New research published on the preprint server bioRxiv* performed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic simulations to understand the evolutionary transition from a bat-adapted SARS-CoV-2 to a human-adapted virus. The findings show that adaptive mutations in viral lineages over time contributed to genomic diversity, including mutations capable of escaping the immune response.

The researchers write:

“Both [microbial long-term evolution experiments] and our analysis suggest that temporal linkage among mutations is a sensitive means for identifying emerging human-adaptive mutations and vaccine-escape mutations, particularly when mutation frequencies are tracked at the local and regional levels.”

Increasing genomic surveillance and profiling high-frequency clusters of missense mutations would help develop therapeutics and vaccine targeting viral variants.

Study: Following the Trail of One Million Genomes: Footprints of SARS-CoV-2 Adaptation to Humans. Image Credit: Binturong-tonoscarpe / Shutterstock

Collecting data to form the CovSimulator software

The researchers used the first known SARS-CoV-2 genome collected from Wuhan, China, in December 2019 to serve as the CovSimulator — a model simulating the evolution of the genome.

When looking at approximately 1 million SARS-CoV-2 genomes up to March 31, 2021, a custom database was created and profiled 815,402 genomes. About 70% of mutations from genomes were single-nucleotide substitutions, including C>T or G>T substitutions.

Rise of hyper-mutated viral variants

The researchers took about 100 genome samples from six continents — excluding Antarctica — to look at mutational differences. They found the rate of mutations varied in viral samples circulating in Asia, Europe, Oceania, and South America since October 2020.

The emergence of variants after October 2020 appeared to be attributed to multiple missense mutations with little viral genome divergence. However, the researchers note the missense divergence happened before the emergence of new viral lineages in North America.

Rates of synonymous and nonsynonymous divergence of SARS-CoV-2 genomes
Rates of synonymous and nonsynonymous divergence of SARS-CoV-2 genomes

Driving forces behind SARS-CoV-2 mutations

Variants with beneficial mutations that allowed it to survive and spread overtook the original SARS-CoV-2 strain as the dominant viral lineage.

While mutations were expected to occur with the virus, the researchers questioned whether SARS-CoV-2 accelerated its mutation rate because of other outside forces.

Simulation of the SARS-CoV-2 genome showed high genomic diversity in the six continents during 2020. “Clearly, the global viral populations are far from reaching an equilibrium level of genomic diversity as the virus has spread within and across continents, mirroring the failures in local and global outbreak control. Furthermore, the increasing genomic diversity may be a reflection of increasing admixture of viral subpopulations distributed across the continents,” wrote the team.

Another potential factor towards viral genomic diversity was the relaxation of selective constraints and adaptive mutations.

Mixed SARS-CoV-2 evolution

Despite most missense mutations being deleterious, adaptive mutations and strong genome-wide linkage disequilibrium appeared to be the main drivers behind genomic variability, suggesting SARS-CoV-2 underwent a mixed genome evolution.

When sampling 20 SARS-CoV-2 genomes, there was a shortened time since the most recent common ancestor. There were also 11 out of 19 adaptive mutations that dominated the viral population.

“Critically, it is clear from the Muller diagrams that within each “genotype” (e.g., G1, G2, G3, G8, and G9), at least one genetic change was the driver adaptive mutation.”

Characterizing adaptive mutations

The mixed SARS-CoV-2 genomic evolution model showed that adaptive mutations were frequent among single-nucleotide variations. About 10.9% of missense mutations were adaptive mutations in a population sample of genomes. In 31 missense mutations, 45% of adaptive mutations reached a frequency of 0.5% or higher.

The rate of adaptive mutations among missense mutations increased over time.

Twenty genomes from the previous viral generation showed fixed missense mutations were comprised of 70% adaptive mutations, 20% deleterious mutations, and 10% neutral mutations. At least one — G1, G2, G3, G8, and G9 — were adaptive drivers for mutation in clusters of mutations.

The researchers next looked at the mutation rate over time for each continent. There were approximately 52 missense mutations on the SARS-CoV-2 spike protein with more than 5% frequency in at least a month.

These mutations, including the D614G substitution, appeared to form in clusters that were distributed worldwide. Other spike protein mutations that make up several variants of concern, such as B.1.351, were also identified.

But not all variants and their associated mutations experienced a global transmission. When researchers looked at missense mutations in SARS-CoV-2 genomes circulating in the United States, they found most mutations reached only the 5% threshold at the state level — with the exception of mutations associated with the B.1.1.7, B.1.427, and B.1.429 lineages.

*Important Notice

bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Jocelyn Solis-Moreira

Written by

Jocelyn Solis-Moreira

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Solis-Moreira, Jocelyn. (2021, May 19). How SARS-CoV-2 evolved from a bat-to a human-adapted virus. News-Medical. Retrieved on July 26, 2021 from https://www.news-medical.net/news/20210519/How-SARS-CoV-2-evolved-from-a-bat-to-a-human-adapted-virus.aspx.

  • MLA

    Solis-Moreira, Jocelyn. "How SARS-CoV-2 evolved from a bat-to a human-adapted virus". News-Medical. 26 July 2021. <https://www.news-medical.net/news/20210519/How-SARS-CoV-2-evolved-from-a-bat-to-a-human-adapted-virus.aspx>.

  • Chicago

    Solis-Moreira, Jocelyn. "How SARS-CoV-2 evolved from a bat-to a human-adapted virus". News-Medical. https://www.news-medical.net/news/20210519/How-SARS-CoV-2-evolved-from-a-bat-to-a-human-adapted-virus.aspx. (accessed July 26, 2021).

  • Harvard

    Solis-Moreira, Jocelyn. 2021. How SARS-CoV-2 evolved from a bat-to a human-adapted virus. News-Medical, viewed 26 July 2021, https://www.news-medical.net/news/20210519/How-SARS-CoV-2-evolved-from-a-bat-to-a-human-adapted-virus.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Study compares mRNA and adenovirus-based SARS-CoV-2 vaccines against variants of concern